Prognostic significance of urine cytology on initial follow-up after intravesical mitomycin C for superficial bladder cancer

J. D. Cant, W. M. Murphy, M. S. Soloway

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Seventy patients were given courses of intravesical mitomycin C for residual transitional cell carcinoma of the bladder following partial resection or biopsy. The patients were reassessed 3 months after the initiation of treatment by cystoscopy and cytology from cystoscopic urines and bladder washings. Twelve had no visible cancer at cystoscopic study but had positive urine cytologic findings. The incidence of tumor recurrence, cystectomy, radiotherapy, and deaths due to bladder cancer for this group of cytologically positive partial responders were analyzed. Thirty-three percent (4/12) required cystectomy, none underwent radiation therapy and none died of bladder cancer. These outcomes were compared with that of complete responders (negative cystoscopic and cytologic results) and partial responders with visible tumor (reduction by > 50%). We conclude that in high-grade carcinomas, particularly carcinoma in situ, positive urine cytologic findings at the initial 3-month follow-up visit following treatment with intravesical mitomycin C is as ominous a prognostic indicator as endoscopic or biopsy evidence of cancer.

Original languageEnglish
Pages (from-to)2119-2122
Number of pages4
JournalCancer
Volume57
Issue number11
StatePublished - Jan 1 1986
Externally publishedYes

Fingerprint

Mitomycin
Urinary Bladder Neoplasms
Cell Biology
Urine
Cystectomy
Neoplasms
Urinary Bladder
Radiotherapy
Biopsy
Cystoscopy
Transitional Cell Carcinoma
Carcinoma in Situ
Carcinoma
Recurrence
Incidence
Therapeutics

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Prognostic significance of urine cytology on initial follow-up after intravesical mitomycin C for superficial bladder cancer. / Cant, J. D.; Murphy, W. M.; Soloway, M. S.

In: Cancer, Vol. 57, No. 11, 01.01.1986, p. 2119-2122.

Research output: Contribution to journalArticle

Cant, J. D. ; Murphy, W. M. ; Soloway, M. S. / Prognostic significance of urine cytology on initial follow-up after intravesical mitomycin C for superficial bladder cancer. In: Cancer. 1986 ; Vol. 57, No. 11. pp. 2119-2122.
@article{598a8373f2934205a07389e6b330afcf,
title = "Prognostic significance of urine cytology on initial follow-up after intravesical mitomycin C for superficial bladder cancer",
abstract = "Seventy patients were given courses of intravesical mitomycin C for residual transitional cell carcinoma of the bladder following partial resection or biopsy. The patients were reassessed 3 months after the initiation of treatment by cystoscopy and cytology from cystoscopic urines and bladder washings. Twelve had no visible cancer at cystoscopic study but had positive urine cytologic findings. The incidence of tumor recurrence, cystectomy, radiotherapy, and deaths due to bladder cancer for this group of cytologically positive partial responders were analyzed. Thirty-three percent (4/12) required cystectomy, none underwent radiation therapy and none died of bladder cancer. These outcomes were compared with that of complete responders (negative cystoscopic and cytologic results) and partial responders with visible tumor (reduction by > 50{\%}). We conclude that in high-grade carcinomas, particularly carcinoma in situ, positive urine cytologic findings at the initial 3-month follow-up visit following treatment with intravesical mitomycin C is as ominous a prognostic indicator as endoscopic or biopsy evidence of cancer.",
author = "Cant, {J. D.} and Murphy, {W. M.} and Soloway, {M. S.}",
year = "1986",
month = "1",
day = "1",
language = "English",
volume = "57",
pages = "2119--2122",
journal = "Cancer",
issn = "0008-543X",
publisher = "John Wiley and Sons Inc.",
number = "11",

}

TY - JOUR

T1 - Prognostic significance of urine cytology on initial follow-up after intravesical mitomycin C for superficial bladder cancer

AU - Cant, J. D.

AU - Murphy, W. M.

AU - Soloway, M. S.

PY - 1986/1/1

Y1 - 1986/1/1

N2 - Seventy patients were given courses of intravesical mitomycin C for residual transitional cell carcinoma of the bladder following partial resection or biopsy. The patients were reassessed 3 months after the initiation of treatment by cystoscopy and cytology from cystoscopic urines and bladder washings. Twelve had no visible cancer at cystoscopic study but had positive urine cytologic findings. The incidence of tumor recurrence, cystectomy, radiotherapy, and deaths due to bladder cancer for this group of cytologically positive partial responders were analyzed. Thirty-three percent (4/12) required cystectomy, none underwent radiation therapy and none died of bladder cancer. These outcomes were compared with that of complete responders (negative cystoscopic and cytologic results) and partial responders with visible tumor (reduction by > 50%). We conclude that in high-grade carcinomas, particularly carcinoma in situ, positive urine cytologic findings at the initial 3-month follow-up visit following treatment with intravesical mitomycin C is as ominous a prognostic indicator as endoscopic or biopsy evidence of cancer.

AB - Seventy patients were given courses of intravesical mitomycin C for residual transitional cell carcinoma of the bladder following partial resection or biopsy. The patients were reassessed 3 months after the initiation of treatment by cystoscopy and cytology from cystoscopic urines and bladder washings. Twelve had no visible cancer at cystoscopic study but had positive urine cytologic findings. The incidence of tumor recurrence, cystectomy, radiotherapy, and deaths due to bladder cancer for this group of cytologically positive partial responders were analyzed. Thirty-three percent (4/12) required cystectomy, none underwent radiation therapy and none died of bladder cancer. These outcomes were compared with that of complete responders (negative cystoscopic and cytologic results) and partial responders with visible tumor (reduction by > 50%). We conclude that in high-grade carcinomas, particularly carcinoma in situ, positive urine cytologic findings at the initial 3-month follow-up visit following treatment with intravesical mitomycin C is as ominous a prognostic indicator as endoscopic or biopsy evidence of cancer.

UR - http://www.scopus.com/inward/record.url?scp=0022613192&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022613192&partnerID=8YFLogxK

M3 - Article

C2 - 3084057

AN - SCOPUS:0022613192

VL - 57

SP - 2119

EP - 2122

JO - Cancer

JF - Cancer

SN - 0008-543X

IS - 11

ER -